“…Drugs under development that specifically inhibit Lp-PLA2 activity have been shown to lower Lp-PLA2 activity and inflammatory markers (199 Epidemiological studies have shown that abnormalities on a resting 12-lead ECG are predictive of subsequent mortality and cardiovascular events among asymptomatic adults (200,202,205,206). Specific electrocardiographic findings that have been linked to cardiovascular risk in populationbased cohorts and asymptomatic patients with hypertension include LVH (especially when accompanied by repolarization changes), QRS prolongation, ST-segment depression, T-wave inversion, and pathological Q waves (202,(207)(208)(209)(210)(211). Several studies suggest that subtle electrocardiographic abnormalities detectable only by computer analysis may also be associated with increased risk (212)(213)(214).…”